Previous close | 0.0900 |
Open | 0.0400 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 50.00 |
Expiry date | 2024-06-21 |
Day's range | 0.0400 - 0.0900 |
Contract range | N/A |
Volume | |
Open interest | 607 |
Key Insights Moderna to hold its Annual General Meeting on 6th of May CEO Stephane Bancel's total compensation includes...
Investors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its late-stage pipeline candidates when it reports first-quarter earnings.
Beyond analysts' top -and-bottom-line estimates for Moderna (MRNA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.